CHE

Chemed authorizes additional $300M for stock repurchase

Chemed (CHE) announced that the board of directors has formally authorized an additional $300M for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The board has declared a quarterly cash dividend of 50c per share on the company’s capital stock, payable on December 6 to shareholders of record as of November 18. This is equal to the dividend paid in August 2024, the company noted.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on CHE:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.